Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Roche Holding AG

+ Add to Watchlist

ROG:VX

270.300 CHF 5.300 2.00%

As of 05:25:13 ET on 03/31/2015.

Snapshot for Roche Holding AG (ROG)

Open: 267.000 Day's Range: 266.700 - 270.500 Volume: 615,707
Previous Close: 265.000 52wk Range: 238.800 - 295.800 1-Yr Rtn: +5.15%

Stock Chart for ROG

No chart data available.
  • ROG:VX 270.200
  • 1D
  • 1M
  • 1Y
265.000
Interactive ROG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ROG

Current P/E Ratio (ttm) 24.4586
Estimated P/E(12/2015) 19.2774
Relative P/E vs. SMI 1.3048
Earnings Per Share (CHF) (ttm) 10.9900
Est. EPS (CHF) (12/2015) 13.9490
Est. PEG Ratio 3.6222
Market Cap (M CHF) 231,568.85
Shares Outstanding (M) 702.56
30 Day Average Volume 1,654,874
Price/Book (mrq) 11.7270
Price/Sale (ttm) 4.8324
Dividend Indicated Gross Yield 2.98%
Cash Dividend (CHF) 8.0000
Dividend Ex-Date 03/05/2015
5 Year Dividend Growth 5.92%
Next Earnings Announcement 07/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ROG

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for ROG

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Severin SchwanChief Executive OfficerAlan HippeChief Financial & IT Officer
Roland DiggelmannCOO:DiagnosticsGottlieb A KellerGeneral Counsel
More Company Profile & Key Executives for ROG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil